MedPath

"Remind to Move" Treatment Versus Constraint-induced Movement Therapy for Children With Hemiplegic Cerebral Palsy

Not Applicable
Completed
Conditions
Upper Extremity Hemiplegia
Hemiplegic Cerebral Palsy
Interventions
Behavioral: Remind-to-move
Behavioral: Conventional rehabilitation
Behavioral: Modified constraint induced movement therapy
Registration Number
NCT02645331
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

The aim of this study was to determine the effects of an innovative child-friendly remind-to-move treatment (RTM) treatment by comparing it with constraint-induced movement therapy (CIMT) on upper extremity outcomes in children with hemiplegic Cerebral Palsy. In an evaluator-blinded randomized controlled trial, 73 children, among of whom 20 in Manual Ability Classification System level I, 38 level II, and 15 level III, were recruited from 3 special schools and randomized to receive 75-hour RTM (n=25) and CIMT (n=24) programme over 15-weekdays, and conventional treatment (n=24). The primary outcomes were Jebsen-Taylor Hand Function Test (JTHFT) and Bruininks-Oseretsky Test of Motor Proficiency (BOTMP-II) Subtest 3 for assessing the motor efficiency at baseline, posttest, and 1- and 3-month follow-up.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
73
Inclusion Criteria
  • Diagnosis of Hemiplegic Cerebral Palsy
  • Aged 5 to 16 years
  • Ability to follow instructions
  • Ability to grasp and release light objects, and at least 20° wrist and 10°fingers in metacarpophalangeal joints extension from full flexion for the affected hand
  • Manual Activity Classification System (MACS) 19 grades I, II or III of the affected hand
Exclusion Criteria
  • Severe cognitive, visual, or auditory disorder
  • Seizure and health problems not associated with cerebral palsy
  • Predominant spasticity or contracture grades more than 3 of Modified Ashworth Scale 20 on wrist and finger flexors, forearm pronators and ⁄ or thumb adductors
  • Receiving new pharmaceutical (i.e. botulinum toxin injections) and/or surgical interventions within 6-month before study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Remind-to-moveRemind-to-moveRTM involved a wristwatch device worn on more-affected arm which emitted sensory cueing continuously to remind the children to use the more-affected hand to engage in daily activities or complete bimanual tasks intensively, 5 hour per day, 5 days every week, for 3 consecutive weeks.
Conventional rehabilitationConventional rehabilitationConventional splinting, muscle strengthening, stretching, and neurodevelopmental facilitation techniques for 1hr daily, 2 day per week for 3 weeks.
Modified constraint induced movement therapy (mCIMT)Modified constraint induced movement therapychildren were encouraged to wear a customer-made volar resting splint that extended from below the elbow to the fingertips on their noninvolved hands for 5 hour daily except for toileting, writing and specific physical sports, for 3 weeks. Each child was supervised by one therapist to complete structured unimanual practice with the affected hand during the supervised session, 5 days every week, for 3 consecutive weeks.
Primary Outcome Measures
NameTimeMethod
Jebsen-Taylor Hand Function Test (JTHFT)Change from Baseline at 3 weeks (plus follow up at 1 month and 3 months after training)
Bruininks-Oseretsky Test of Motor Proficiency (2nd ed.) (BOTMP-II)Change from Baseline at 3 weeks (plus follow up at 1 month and 3 months after training)
Secondary Outcome Measures
NameTimeMethod
Caregiver Functional Use Survey (CFUS)Change from Baseline at 3 weeks (plus follow up at 1 month and 3 months after training)
Ratio of movement duration on the affected hand from accelerometerChange from Baseline at 3 weeks (plus follow up at 1 month and 3 months after training)
Active range of motion (AROM) as measured by digital goniometerChange from Baseline at 3 weeks (plus follow up at 1 month and 3 months after training)
Power grip strength as measured by dynamometerChange from Baseline at 3 weeks (plus follow up at 1 month and 3 months after training)
© Copyright 2025. All Rights Reserved by MedPath